Sheehy Christine Elise 4

What Happened
Christine Elise Sheehy, VP Compliance & Secretary of Coeptis Therapeutics Holdings, acquired shares via two transactions on 2026-02-11. She exercised stock options to buy 1,000 shares at an exercise price of $10.56 per share (total cash paid $10,560). She also received a grant of 12,500 restricted shares (no cash cost), issued in connection with an option-exchange program.

Key Details

• Transaction dates: 2026-02-11 (reported on Form 4 filed 2026-02-13).
• Option exercise (code M): 1,000 shares at $10.56 each; total exercise payment = $10,560. (Footnote F1: $10.56 is the option exercise price.)
• Grant/award (code A): 12,500 restricted shares issued at $0.00 (Footnote F2: restricted stock issued in exchange for surrendered underwater options).
• Shares owned after the transactions: not specified in the provided filing excerpt.
• 10b5-1 / trading plan: none reported.
• Filing timeliness: Form 4 filed two days after the transaction date (filed 2026-02-13 for 2026-02-11), which is within the typical two-business-day reporting window.

Context

• The option exercise required payment of the exercise price (not a cashless sale); no immediate sale of shares was reported.
• The 12,500 restricted shares were issued as part of an option-exchange program (surrender of underwater options), per the filing footnote — these restricted shares typically carry transfer and vesting limits.
• Both entries are acquisitions (not sales); acquisitions can be informative but do not by themselves indicate the insider’s broader view of the company.